Quality of Life and Health Status in Sarcoidosis: A Review

ABSTRACT

The aim of this review is to provide information on the influence of sarcoidosis on patients' quality of life (QOL) and health status (HS), a related concept. A search in the PubMed database was performed with the key words sarcoidosis and health status and sarcoidosis and quality of life. After removing double hits, reviews, articles written in a language other than English or Dutch, guidelines, articles focusing on questionnaire development or validation, and articles in which QOL or HS was not assessed, 28 articles were left for inclusion in the present review. The HS and QOL of sarcoidosis patients is negatively affected by the disease. Symptoms have an additional negative impact on patients' lives. Sarcoidosis has a substantial impact on patients' HS and QOL. Present observational studies all have a cross-sectional design. Prospective longitudinal follow-up studies are lacking, which makes inferences about cause and consequences difficult.

KEYWORDS

Sarcoidosis - quality of life - health status - review

REFERENCES

• 1 Loddenkemper R, Kloppenborg A, Schoenfeld N, Grosser H, Costabel U. Clinical findings in 715 patients with newly detected pulmonary sarcoidosis-results of a cooperative study in former West Germany and Switzerland. WATL Study Group. Wissenschaftliche Arbeitsgemeinschaft fur die Therapie von Lungenkrankheitan.  Sarcoidosis Vasc Diffuse Lung Dis. 1998;  15 178-182
• 2 Klonoff E A, Kleinhenz M E. Psychological factors in sarcoidosis: the relationship between life stress and pulmonary function.  Sarcoidosis. 1993;  10 118-124
• 3 Hoitsma E, Marziniak M, Faber C G et al.. Small fiber neuropathy in sarcoidosis.  Lancet. 2002;  359 2085-2086
• 4 Wirnsberger R M, De Vries J, Wouters E F, Drent M. Clinical presentation of sarcoidosis in the Netherlands: an epidemiological study.  Neth J Med. 1998;  53 53-60
• 5 Drent M, Wirnsberger R M, Breteler M H, Kock L M, De Vries J, Wouters E F. Quality of life and depressive symptoms in patients suffering from sarcoidosis.  Sarcoidosis Vasc Diffuse Lung Dis. 1998;  15 59-66
• 6 Wirnsberger R M, De Vries J, Breteler M H, Van Heck G L, Wouters E F, Drent M. Evaluation of quality of life in sarcoidosis patients.  Respir Med. 1998;  92 750-756
• 7 De Vries J. Quality of life assessment. In: Vingerhoets AJJM Assessment in Behavioural Medicine. Hove, UK; Brunner-Routledge 2001: 353-370
• 8 WHO .The First Ten Years of the World Health Organisation. Geneva, Switzerland; WHO 1958
• 9 Van der Steeg A F, De Vries J, Roukema J A. Quality of life and health status in breast carcinoma.  Eur J Surg Oncol. 2004;  30 1051-1057
• 10 Curtis J R, Patrick D L. The assessment of health status among patients with COPD.  Eur Respir J Suppl. 2003;  41 36s-45s
• 11 De Vries J, Drent M. Quality of life and health status in interstitial lung diseases.  Curr Opin Pulm Med. 2006;  12 E354-E358
• 12 De Vries J, Wirnsberger R M. Fatigue, quality of life, and health status in sarcoidosis.  Eur Respir Monograph. 2005;  10 92-104
• 13 Breek J C, De Vries J, Van Heck G L, Van Berge Henegouwen D P, Hamming J F. Assessment of disease impact in patients with intermittent claudication: discrepancy between health status and quality of life.  J Vasc Surg. 2005;  41 443-450
• 14 Fitzpatrick R, Fletcher A, Gore S, Jones D, Spiegelhalter D, Cox D. Quality of life measures in health care, I: Applications and issues in assessment.  BMJ. 1992;  305 1074-1077
• 15 Jones P W, Quirk F H, Baveystock C M. The St. George's Respiratory Questionnaire.  Respir Med. 1991;  85 25-31
• 16 WHOQOL group .Field Trial WHOQOL-100 February 1995: Facet Definitions and Questions. Geneva, Switzerland; WHO 1995
• 17 WHOQOL group . The World Health Organization Quality of Life assessment (WHOQOL): Position paper from the World Health Organization.  Soc Sci Med. 1995;  41 1403-1409
• 18 O'Carroll R E, Cossar J A, Couston M C, Hayes P C. Sensitivity to change following liver transplantation: a comparison of three instruments that measure quality of life.  J Health Psychol. 2000;  5 69-74
• 19 WHOQOL group . The World Health Organisation Quality of Life assessment (WHOQOL): development and general psychometric properties.  Soc Sci Med. 1998;  46 1569-1585
• 20 De Vries J. Beyond Health Status: Construction and Validation of the Dutch WHO Quality of Life Instrument. Tilburg, the Netherlands; Tilburg University 1996
• 21 Bergner M, Bobbitt R A, Carter W B, Gilson B S. The Sickness Impact Profile: development and final revision of a health-status measure.  Med Care. 1981;  19 787-805
• 22 Bowling A. Measuring Disease: A Review of Disease-Specific Quality of Life Measurement Scales. Buckingham; Open University Press 1995
• 23 Ware Jr J E, Snow K K, Gandek B. SF-36 Health Survey. Manual and Interpretation Guide. Boston; The Health Institute, New England Medical Center 1993
• 24 Chang J A, Curtis J R, Patrick D L, Raghu G. Assessment of health-related quality of life in patients with interstitial lung disease.  Chest. 1999;  116 1175-1182
• 25 Guyatt G H, Berman L B, Townsend M, Pugsley S O, Chambers L W. A measure of quality of life for clinical trials in chronic lung disease.  Thorax. 1987;  42 773-778
• 26 Guyatt G H, Townsend M, Keller J, Singer J, Nogradi S. Measuring functional status in chronic lung disease: conclusions from a randomised control trial.  Respir Med. 1989;  83 293-297
• 27 Wijkstra P J, Ten Vergert E M, Van Altena R et al.. Reliability and validity of the chronic respiratory questionnaire (CRQ).  Thorax. 1994;  49 465-467
• 28 Jones P W, Quirk F H, Baveystock C M, Littlejohns P. A self-complete measure of health status for chronic airflow limitation: the St George's Respiratory Questionnaire.  Am Rev Respir Dis. 1992;  145 1321-1327
• 29 Jones P W, Bosh T K. Quality of life changes in COPD patients treated with salmeterol.  Am J Respir Crit Care Med. 1997;  155 1283-1289
• 30 Jones P W. Nedocromil Sodium Quality of Life Study Group . Quality of life, symptoms and pulmonary function in asthma: long-term treatment with nedocromil sodium examined in a controlled multicentre trial.  Eur Respir J. 1994;  7 55-62
• 31 Cox C E, Donohue J F, Brown C D, Kataria Y P, Judson M A. The Sarcoidosis Health Questionnaire: a new measure of health-related quality of life.  Am J Respir Crit Care Med. 2003;  168 323-329
• 32 Kuyken W, Orley J, Hudelson P, Sartorius N. Quality of life assessment across cultures.  Internat J Mental Health. 1994;  23 5-27
• 33 Floor S, Overbeke A JPM. Non-Dutch questionnaires about life quality used in the Dutch Journal for Medicine: translation procedure and arguments for choice of a questionnaire [in Dutch].  Ned Tijdschr Geneeskd. 2006;  150 1724-1727
• 34 De Vries J, Van Heck G L, Drent M. Gender differences in sarcoidosis: symptoms, quality of life, and medical consumption.  Women Health. 1999;  30 99-114
• 35 Hoitsma E, De Vries J, Van Santen-Hoeufft M, Faber C G, Drent M. Impact of pain in a Dutch sarcoidosis patient population.  Sarcoidosis Vasc Diffuse Lung Dis. 2003;  20 33-39
• 36 Wirnsberger R M, De Vries J, Jansen T L, Van Heck G L, Wouters E F, Drent M. Impairment of quality of life: rheumatoid arthritis versus sarcoidosis.  Neth J Med. 1999;  54 86-95
• 37 Michielsen H J, Peros-Golubicic T, Drent M, De Vries J. Relationship between symptoms and quality of life in a sarcoidosis population.  Respiration. 2006, Apr 7;  , [Epub ahead of print]
• 38 De Vries J, Drent M, Van Heck G L, Wouters E FM. Quality of life in sarcoidosis: a comparison between members of a patient organization and a random sample.  Sarcoidosis Vasc Diffuse Lung Dis. 1998;  15 183-188
• 39 Wirnsberger R M, Drent M, Hekelaar N et al.. Relationship between respiratory muscle function and quality of life in sarcoidosis.  Eur Respir J. 1997;  10 1450-1455
• 40 Antoniou K M, Tzanakis N, Tzouvelekis A et al.. Quality of life in patients with active sarcoidosis in Greece.  Eur J Intern Med. 2006;  17 421-426
• 41 Spruit M A, Thomeer M J, Gosselink R et al.. Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status.  Thorax. 2005;  60 32-38
• 42 Cox C E, Donohue J F, Brown C D, Kataria Y P, Judson M A. Health-related quality of life of persons with sarcoidosis.  Chest. 2004;  125 997-1004
• 43 Chang B, Steimel J, Moller D R et al.. Depression in sarcoidosis.  Am J Respir Crit Care Med. 2001;  163 329-334
• 44 De Vries J, Drent M. Relationship between perceived stress and sarcoidosis in a Dutch patient population.  Sarcoidosis Vasc Diffuse Lung Dis. 2004;  21 57-63
• 45 Yeager H, Rossman M D, Baughman R P et al.. Pulmonary and psychosocial findings at enrollment in the ACCESS study.  Sarcoidosis Vasc Diffuse Lung Dis. 2005;  22 147-153
• 46 Baughman R P, Iannuzzi M C, Lower E E et al.. Use of fluticasone in acute symptomatic pulmonary sarcoidosis.  Sarcoidosis Vasc Diffuse Lung Dis. 2002;  19 198-204
• 47 Judson M A, Silvestri J, Hartung C, Byars T, Cox C E. The effects of thalidomide on corticosteroid-dependent pulmonary sarcoidosis.  Sarcoidosis Vasc Diffuse Lung Dis. 2006;  23 51-57
• 48 Rabin D L, Richardson M SA, Stein S R, Yeager Jr H. Sarcoidosis severity and socioeconomic status.  Eur Respir J. 2001;  18 499-506
• 49 Rabin D L, Thompson B, Brown K M et al.. Sarcoidosis: social predictors of severity at presentation.  Eur Respir J. 2004;  24 601-608
• 50 Stavem K, Bjørtuft Ø, Lund M B, Kongshaug K, Geiran O, Boe J. Health-related quality of life in lung transplant candidates and recipients.  Respiration. 2000;  67 159-165